Luc Choisnard
Overview
Explore the profile of Luc Choisnard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nourry J, Chevalier P, Laurenceau E, Cattoen X, Bertrand X, Peres B, et al.
J Pharm Biomed Anal
. 2025 Jan;
255():116661.
PMID: 39793371
Controlling the spread of bacterial infectious diseases is a major public health issue, particularly in view of the pandemic of bacterial resistance to antibiotics. In this context, the detection and...
2.
Mutin J, Orhon P, Choisnard L, Lassiaz M, Bacot S, Ahmadi M, et al.
J Pharm Biomed Anal
. 2024 May;
246:116224.
PMID: 38759321
Cardiovascular diseases, including fatal myocardial infarctions from atheromatous plaques, are the primary global mortality cause. Detecting stenotic atheromatous plaques is possible through coronary angiography, but vulnerable plaques with eccentric remodeling...
3.
Bosson A, Durand M, Mazet R, Jouannet-Romaszko M, Chennell P, Mounsef F, et al.
Ann Pharm Fr
. 2023 Dec;
82(2):306-317.
PMID: 38159720
Objectives: To assess the impact of disparities in production and analytical control processes on the quality of parenteral nutrition (PN) preparations produced in the Auvergne-Rhône-Alpes region. Methods: This study was...
4.
Leenhardt J, Choisnard L, Plasse M, Ardisson V, De Leiris N, Djaileb L, et al.
EJNMMI Radiopharm Chem
. 2023 Oct;
8(1):34.
PMID: 37882937
Background: The aim of this brief communication is to highlight the potential bacteriological risk linked to the processes control of radiopharmaceutical preparations made in a radiopharmacy laboratory. Survival rate of...
5.
Dagher M, Ersayin A, Seyve L, Castellan M, Moreau C, Choisnard L, et al.
Res Pract Thromb Haemost
. 2023 Oct;
7(6):102175.
PMID: 37841511
Background: Gla-domainless factor (F) Xa (GD-FXa) was proposed as a trap to endogenous anticoagulant tissue factor pathway inhibitor (TFPI) to restore thrombin generation in hemophilia. Using computational chemistry and experimental...
6.
Billet B, Choisnard L, Faure P, Guicherd D, Cussigh E, Peyrin E, et al.
Clin Chem Lab Med
. 2023 Jul;
62(1):e13-e15.
PMID: 37470268
No abstract available.
7.
Leprince M, Mailley P, Choisnard L, Auzely-Velty R, Texier I
Carbohydr Polym
. 2022 Nov;
301(Pt B):120345.
PMID: 36446494
Conformable biocompatible conductive materials are increasingly sought for the development of bioelectronics. If additionally resorbable, they could serve for the design of transient implantable electronic devices, opening the way to...
8.
Lavigne L, Choisnard L, Peyrin E, Oukacine F
Anal Chem
. 2022 Nov;
94(45):15546-15552.
PMID: 36342126
A new analytical methodology, using capillary electrophoresis in indirect UV absorbance mode, is developed for the quantification of analytes in the absence of reference materials. The methodology allows the quantification...
9.
Perrier Q, Piquemal M, Leenhardt J, Choisnard L, Mazet R, Desruet M, et al.
Eur J Pharm Sci
. 2022 Aug;
179:106275.
PMID: 35987326
Automated compounding device (ACD) are increasingly used for parenteral nutrition (PN) bag production, and their acquisition must be sufficiently thought. The law requires the qualification of these ACD, but did...
10.
Putaux J, Lancelon-Pin C, Choisnard L, Geze A, Wouessidjewe D
Soft Matter
. 2022 Feb;
18(10):2028-2038.
PMID: 35191906
Colloidal nanoparticles were prepared by aqueous self-assembly of amphiphilic β-cyclodextrins (βCDs) acylated on their secondary face with C chains to a total degree of substitution of 7.0, a thermolysin-catalyzed transesterification...